Basit öğe kaydını göster

dc.contributor.authorKursunoglu, Sabiha Gokcen
dc.contributor.authorSerdaroglu, Server
dc.contributor.authorBüyükünal, Evin
dc.contributor.authorDemirkesen, Cüyan
dc.contributor.authorÖzgüroğlu, Mustafa
dc.contributor.authorYıldız, Ozcan
dc.contributor.authorAntonov, Meltem
dc.contributor.authorYanmaz, M. Roman
dc.contributor.authorTurna, Hande
dc.date.accessioned2021-03-05T08:04:06Z
dc.date.available2021-03-05T08:04:06Z
dc.date.issued2007
dc.identifier.citationYıldız O., Özgüroğlu M., Yanmaz M. R. , Turna H., Kursunoglu S. G. , Antonov M., Serdaroglu S., Demirkesen C., Büyükünal E., "Paraneoplastic pemphigus associated with fludarabine use", MEDICAL ONCOLOGY, cilt.24, ss.115-118, 2007
dc.identifier.issn1357-0560
dc.identifier.otherav_97044334-ecdb-4ead-87a3-cf5b00cd45e3
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/101658
dc.identifier.urihttps://doi.org/10.1007/bf02685912
dc.description.abstractParaneoplastic pemphigus is a severe mucocutaneous disease associated with B-cell lymphoproliferative disorders. A 51-yr-old man presented to the oncology clinic with mucocutaneous skin lesions after six cycles of fludarabine for non-Hodgkin's lymphoma. A punch biopsy from the skin showed suprabasal acantholysis and blister formation in the epidermis and upper dermis. Direct immunofluorescence demonstrated intercellular IgG deposition in all epidermal layers and complement (C3) at the basement membrane. The indirect immunofluorescence on rat bladder showed intercellular binding of IgG. These findings were consistent with paraneoplastic pemphigus associated with fludarabine use. The temporal association between fludarabine use and paraneoplastic pemphigus suggests there is an etiopathological link between these two entities.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectONKOLOJİ
dc.titleParaneoplastic pemphigus associated with fludarabine use
dc.typeMakale
dc.relation.journalMEDICAL ONCOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume24
dc.identifier.issue1
dc.identifier.startpage115
dc.identifier.endpage118
dc.contributor.firstauthorID22108


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster